Back to Journals » ImmunoTargets and Therapy » Volume 6
Clinical Trial Report
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Phase I clinical trial of sipuleucel-T combined with escalating doses of ipilimumab in progressive metastatic castrate-resistant prostate cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,461 | Dovepress* | 9,230+ | 1,939 | 11,169 | |
PubMed Central* | 1,231 | 373 | 1,604 | ||
Totals | 10,461 | 2,312 | 12,773 | ||
*Since 20 March 2017 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar